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We have considered trends in age-standardized mortality from gastric cancer in 25 individual European coun-
tries, as well as in the European Union (EU) as a whole, in six selected central-eastern European countries and
in the Russian Federation over the period 1950–1999. Steady and persisting falls in rates were observed, and the
fall between 1980 and 1999 was ∼50% in the EU, 45% in eastern Europe and 40% in Russia. However, the
declines were greater in Russia and eastern Europe, since rates were much higher, in absolute terms. Joinpoint
regression analysis indicated that the falls were proportionally greater in the last decade for men (–3.83% per
year in the EU) and in the last 25 years for women (–3.67% per year in the EU) than in previous calendar years.
Moreover, steady declines in gastric cancer mortality were observed in the middle-aged and the young popula-
tion as well, suggesting that they are likely to persist in the near future. In terms of number of deaths avoided,
however, the impact of the decline in gastric cancer mortality will be smaller, particularly in the EU.
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Introduction
Across Europe, major differences in gastric cancer rates are evi-
dent. Thus, gastric cancer rates in Russia are over five-fold higher
than those in Scandinavia or France, and, in general, higher gastric
cancer rates have been registered in central and eastern Europe,
Portugal, Italy and Spain. Consequently, gastric cancer remains a
major public heath issue in several European areas [1–4]. Over the
last few decades, however, substantial declines in gastric cancer
mortality rates have been observed throughout Europe. Of 80 000
fewer cancer deaths observed in the European Union (EU) in 1997
as compared with 1988, 24  000 were due to the fall in gastric
cancer rates [5]. We have therefore systematically reviewed trends
in gastric cancer mortality across Europe over the last two dec-
ades. We have also considered long-term trends (1950–1999) for
18 countries providing data, and the EU, using joinpoint regres-
sion analysis [6].
Materials and methods
Official death certification data from gastric cancer were abstracted from
the WHO database over the period 1950–1999, whenever available (http://www3.
who.int/whosis/menu.cfm). Estimates of the resident population, generally
based on official censuses, were based on the same WHO database.
For the present analysis we considered recent trends in mortality from gastric
cancer for 25 individual European countries and the Russian Federation. Data
for the Russian Federation, and for other Republics included in the former
Soviet Union, have been made available in the WHO database from 1980
onwards. Data for Croatia and Slovenia have been made available since 1985,
those for the Czech Republic since 1986 and those for Slovakia since 1992.
These were subsequently subdivided into the EU, and six central-eastern Euro-
pean countries providing uniform data across the calendar period considered
(Bulgaria, Czech Republic, Hungary, Poland, Romania, Slovakia).
In the 1980s, most countries utilized the Ninth Revision of the International
Classification of Diseases (ICD-9), but some still used ICD-8, and some
adopted the ICD-10 from 1995 onwards. Since differences between various
Figure 1. Trends in overall age-standardized (world population) death 
certification rates (per 100 000) from gastric cancer in men and women in 
the European Union (EU), eastern European countries and the Russian 
Federation in 1980–1999. Key: filled circles, Russian Federation, male; 
open circles, Russian Federation, female; filled squares, eastern European 
countries, male; open squares, eastern European countries, female; crosses 
on solid line, EU, male; crosses on dashed line, EU, female.
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revisions were minor, gastric cancer deaths were re-coded for all countries
according to the ICD-9 (code no. 151) [3, 7].
From the matrices of certified deaths and resident populations, age-standard-
ized rates at all ages, at age 35–64 years and at age 20–44 years were computed
on the basis of the world standard population.
The joinpoint regression model was used to describe changes in trends. This
type of non-linear regression model has also been called ‘piecewise regression’,
‘segmented regression’, ‘broken line regression’ and/or ‘multi-phase regres-
sion with the continuity constraint’ in the literature [6]. In joinpoint analysis,
the best fitting points (the ‘joinpoints’) are chosen where the rate changes
significantly (increase or decrease) [6, 8]. The analysis starts with the mini-
mum number of joinpoint (e.g. zero joinpoints, which is a straight line) and
tests whether one or more joinpoints are significant and must be added to
the model (up to four joinponts). The tests of significance use a Monte Carlo
permutation method. In the final model each joinpoint (if any) informs of a
significant change in trend, and an annual percentage change is computed by
each of those trends by means of generalized linear models, assuming a Pois-
son distribution. Significant changes include changes in direction or in the rate
of increase or decrease. The annual percentage change is tested to determine
whether it is different from the null hypothesis of no change [8]. The joinpoint
analyses were performed using the ‘Joinpoint’ software from the Surveillance
Research Program of the US National Cancer Institute (available at http://
www-dccps.ims.nci.nih.gov/SRAB).
Results
Figure 1 gives trends in overall age-standardized gastric cancer
mortality in the EU, selected central-eastern European countries
and the Russian Federation between 1980 and 1999. The fall in the
Table 1. Overall age-adjusted (world population) mortality rates from gastric cancer per 100 000 men and women in separate European countries in 
1980, 1989 and 1999 (unless otherwise stated in parenthesesa), and corresponding changes in rates
aThe first and last year available are given in parentheses.
EU, European Union.
Men Women








Austria 25.80 16.77 9.89 –35.00 –41.03 12.06 8.55 5.35 –29.10 –37.43
Belarus (1981) 40.43 38.69 32.97 –4.30 –14.78 17.62 15.98 13.02 –9.31 –18.52
Bulgaria 23.07 20.16 14.91 –12.16 –26.04 13.11 10.49 7.49 –19.98 –28.60
Croatia (1985) 26.92 24.83 22.79 –7.76 –8.22 11.01 9.80 7.49 –10.99 –23.57
Czech Rep. (1986) 19.89 11.73 –41.03 9.07 5.88 –35.17
Denmark (1998) 12.17 7.52 5.18 –38.21 –31.12 6.32 4.29 2.69 –32.12 –37.30
Estonia (1981) 34.25 31.18 22.84 –8.96 –26.75 15.38 15.20 11.79 –1.17 –22.43
Finland 18.78 13.06 7.89 –30.46 –39.59 10.64 7.90 3.64 –25.75 –53.92
France (1998) 12.42 8.92 6.78 –28.18 –23.99 5.42 3.54 2.52 –34.69 –28.81
Germany 21.32 15.20 9.94 –28.71 –34.61 10.87 7.81 5.19 –28.15 –33.55
Greece (1998) 11.66 9.15 8.48 –21.53 –7.32 6.37 4.98 3.92 –21.82 –21.29
Hungary 31.01 23.57 18.51 –23.99 –21.47 13.59 10.50 7.76 –22.74 –26.10
Ireland (1998) 17.45 11.58 8.29 –33.64 –28.41 8.23 5.82 3.93 –29.28 –32.47
Italy (1998) 22.47 17.64 12.56 –21.50 –28.80 10.53 8.33 5.87 –20.89 –29.53
The Netherlands 17.42 13.12 8.47 –24.68 –35.44 7.11 5.04 3.55 –29.11 –29.56
Norway (1998) 13.57 11.29 7.57 –16.80 –32.95 7.59 5.16 3.72 –32.02 –27.91
Poland 30.79 23.13 16.52 –24.88 –28.58 11.75 8.47 5.70 –27.91 –32.70
Portugal 31.43 25.07 20.19 –20.24 –19.47 15.13 12.11 9.43 –19.96 –22.13
Romania 25.58 18.70 16.67 –26.90 –10.86 11.11 7.01 6.08 –36.90 –13.27
Russian Federation (1998) 51.61 42.04 32.04 –18.54 –23.79 22.60 18.20 13.45 –19.47 –26.10
Slovakia (1992) 17.56 16.69 –4.95 7.33 5.84 –20.33
Slovenia (1985) 26.89 24.44 17.82 –9.11 –27.09 11.81 9.51 7.67 –19.48 –19.35
Spain (1998) 19.39 14.71 11.17 –24.14 –24.07 9.19 6.82 4.67 –25.79 –31.52
Sweden (1998) 12.40 8.85 6.14 –28.63 –30.62 6.91 4.19 2.78 –39.36 –33.65
UK 16.92 12.93 8.09 –23.58 –37.43 7.52 5.28 3.26 –29.79 –38.26
Ukraine (1981) 33.47 32.30 24.86 –3.50 –23.03 14.02 12.98 9.58 –7.42 –26.19
EU 18.61 13.85 9.80 –34.37 –29.24 8.94 6.50 4.57 –27.29 –29.69
Eastern European countries 27.90 21.27 16.06 –31.17 –24.49 12.19 8.73 6.26 –28.38 –28.29
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EU was ∼50% in both sexes, from 18.6 to 9.8/100 000 males, and
from 8.9 to 4.6/100 000 females. In selected central European
countries, the fall was 49% in men and 48% in women. In absolute
terms, however, the decline was larger in central Europe (from
27.9 to 16.1/100 000 men, and from 12.2 to 6.3/100 000 women).
Thus, for both sexes the rates registered in central Europe in the
late 1990s are similar to those of the EU in the mid-1980s. In the
Russian Federation, the fall during the last 20 years was 38% in
men (from 51.6 to 32/100 000) and 40% in women (from 22.6 to
13.5/100 000), and the rates of the late 1990s were comparable to
those registered in the EU as a whole three decades earlier.
Table 1 gives overall age-adjusted gastric cancer rates for men
and women in separate European countries in 1980, 1989 and
1999, and the corresponding fall in rates. For men, some countries
(e.g. Denmark, France, Greece, Hungary or Ireland) but not others
(e.g. Finland, Germany, Italy, The Netherlands or the UK) showed
greater proportional falls in the 1980s than in the 1990s. Overall,
the fall in men was 34% in the 1980s and 29% in the 1990s in the
EU, 31% and 24% in eastern Europe, and 19% and 24% in Russia.
For women, the fall was similar in the two decades in most of
Europe, approaching 30%.
Corresponding figures at age 35–64 years are given in Table 2.
Although there was some variation across countries, the pattern
of trends was similar to that registered at all ages, with a 25–30%
fall for both sexes in all major areas of the continent over the last
decade.
Table 2. Age-adjusted (world population) mortality rates from gastric cancer per 100 000 men and women aged 35–64 years in separate European 
countries in 1980, 1989 and 1999 (unless otherwise stated in parenthesesa), and corresponding changes in rates
aThe first and last year available are given in parentheses.
EU, European Union.
Men Women








Austria 28.39 17.59 9.14 –38.04 –48.04 13.05 9.21 5.34 –29.43 –42.02
Belarus (1981) 72.21 66.98 52.48 –7.24 –21.65 28.71 24.23 19.35 –15.60 –20.14
Bulgaria 31.66 27.89 21.03 –11.91 –24.60 16.39 12.62 9.90 –23.00 –21.55
Croatia (1985) 36.52 31.54 25.60 –13.64 –18.83 13.48 11.32 7.04 –16.02 –37.81
Czech Rep. (1986) 23.17 14.66 –36.73 8.65 6.97 –19.42
Denmark (1998) 12.52 10.71 7.51 –14.46 –29.88 7.51 6.36 2.72 –15.31 –57.23
Estonia (1981) 53.89 46.46 33.65 –13.79 –27.57 21.42 23.38 17.64 +9.15 –24.55
Finland 20.04 13.56 9.58 –32.34 –29.35 12.38 8.62 3.87 –30.37 –55.10
France (1998) 13.73 9.89 7.75 –27.97 –21.64 5.05 3.30 2.67 –34.65 –19.09
Germany 22.79 16.59 10.84 –27.20 –34.66 11.05 8.61 5.93 –22.08 –31.13
Greece (1998) 16.19 12.26 11.24 –24.27 –8.32 7.06 5.45 4.39 –22.80 –19.45
Hungary 37.05 28.65 22.39 –22.67 –21.85 14.05 12.49 8.70 –11.10 –30.34
Ireland (1998) 20.89 14.31 7.70 –31.50 –46.19 8.19 5.33 3.38 –34.92 –36.59
Italy (1998) 27.43 19.11 14.04 –30.33 –26.53 11.07 8.43 6.88 –23.85 –18.39
The Netherlands 18.62 13.29 8.66 –28.63 –34.84 6.70 4.81 3.91 –28.21 –18.71
Norway (1998) 13.40 11.53 6.80 –13.96 –41.02 8.12 6.21 4.51 –23.52 –27.38
Poland 42.73 31.65 21.44 –25.93 –32.26 14.76 10.32 6.74 –30.08 –34.69
Portugal 47.61 33.12 25.42 –30.43 –23.25 19.59 15.26 12.31 –22.10 –19.33
Romania 36.74 29.84 26.02 –18.78 –12.80 14.46 9.82 7.90 –32.09 –19.55
Russian Federation (1998) 87.03 69.13 50.18 –20.57 –27.41 34.25 26.74 19.05 –21.93 –28.76
Slovakia (1992) 23.80 22.74 –4.45 8.32 6.48 –22.12
Slovenia (1985) 31.94 31.01 18.33 –2.91 –40.89 12.25 10.87 9.68 –11.27 –10.95
Spain (1998) 24.95 17.56 13.97 –29.62 –20.44 9.37 7.37 5.57 –21.34 –24.42
Sweden (1998) 11.46 8.75 6.21 –23.65 –29.03 8.28 4.56 3.70 –44.93 –18.86
UK 18.95 13.54 7.67 –28.55 –43.35 7.43 5.19 3.14 –30.15 –39.50
Ukraine (1981) 59.64 55.16 42.95 –7.51 –22.14 23.31 20.50 15.86 –12.05 –22.63
EU 21.56 15.47 10.74 –28.25 –30.58 9.31 6.92 4.98 –25.67 –28.03
Eastern European countries 36.96 29.32 21.81 –20.67 –25.61 14.48 10.45 7.55 –27.83 –27.75
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Figure 2. Joinpoint analysis (1950–1999) for gastric cancer mortality in selected European countries. Males, all ages and 35–64 years old.
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To further understand cohort patterns in gastric cancer mortal-
ity, we also considered trends in young adults (20–44 years) only.
Persisting falls were observed in the EU (∼27% in the 1980s, and
20% in the 1990s in both sexes combined), in eastern Europe
(∼20% in both decades) and in Russia (30% in the 1980s, 25% in
the 1990s). Only France and Greece, two countries with low rates,
did not show consistent declines in both sexes over the last decade.
The main findings from joinpoint regression over the period
1950–1999 in 20 European countries providing long-term data,
the EU, and selected central and eastern European countries are
given in Figure 2 and Table 3 for men. Apart from some central
(Hungary, Poland) and southern (Spain, Portugal) European coun-
tries, whose downward trends started in the 1960s, most countries
showed falls in gastric cancer mortality throughout the five dec-
ades considered. These were, if anything, larger after the 1960s
and 1970s, and showed no evidence of levelling off, in propor-
tional terms. Indeed, in the whole EU, the largest proportional
decline (–3.83% per year) was observed in the 1990s. As shown in
Figure 2, the pattern was similar at age 35–64 years.
Comparable figures for women are given in Figure 3 and Table
4. As for men, trends were downward in all countries over recent
decades, and the proportional decline was, if anything, larger
since the mid-1970s, as indicated by the figure for the EU as a
whole (–3.67% after 1974).
Discussion
The major finding from this update analysis of trends in gastric
cancer mortality in Europe is the steady and persistent fall in rates
across various major geographical areas of the continent. There
was little systematic indication of a levelling of slopes over the
most recent calendar years, indicating that the fall is likely to
continue in the near future. With respect to this, the decline was
observed in the young and middle-aged population as well, and
hence the fall in gastric cancer across Europe has mainly been on a
cohort of birth basis [1, 9]. The lowest gastric cancer rates in the
late 1990s were registered in Denmark (5.2/100 000 men; 2.7/100
000 women); nonetheless, the fall over the last decade was over
Table 3. Joinpoint analysis (1950–1999) for gastric cancer (males, all ages)
*The APC is statistically significantly different from 0 (P <0.05).
APC, annual percentage change.
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Years APC Years APC Years APC Years APC Years APC
Austria 1955–67 –1.45* 1967–93 –3.77* 1993–99 –6.39
Belgium 1954–63 –1.39* 1963–82 –3.55 1982–95 –4.71*
Bulgaria 1964–75 –3.41* 1975–99 –2.49*
Former Czech Rep. 1953–66 –0.82* 1966–91 –3.43*
Denmark 1951–55 –0.85 1955–98 –3.96*
Finland 1952–91 –4.40*
France 1950–61 –1.38* 1961–98 –3.61*
Germany 1955–65 –1.66* 1965–75 –3.34* 1975–85 –4.13* 1985–95 –3.29* 1995–99 –5.69*
Greece 1961–76 –2.24* 1976–98 –2.87*
Hungary 1955–59 0.71 1959–78 –1.76* 1978–86 –4.03* 1986–92 –1.00 1992–99 –3.63*
Ireland 1950–71 –1.36* 1971–98 –3.17*
Italy 1951–65 –0.54* 1965–72 –1.88* 1972–76 –5.03* 1976–84 –1.59* 1984–98 –3.76*
The Netherlands 1950–74 –2.68* 1974–92 –3.32* 1992–99 –4.77*
Norway 1951–62 –4.36* 1962–68 –1.52 1968–74 –5.45* 1974–98 –3.17*
Poland 1959–63 6.47* 1963–87 –2.47* 1987–99 –3.70*
Portugal 1955–71 1.35* 1971–99 –2.14*
Romania 1959–61 7.56 1961–80 –2.10* 1980–83 –6.90 1983–99 –1.40*
Spain 1951–64 1.53* 1964–76 –2.33* 1976–82 –5.34* 1982–98 –2.52*
Sweden 1951–62 –2.32 1962–68 –5.14* 1968–74 –1.90* 1974–98 –4.20*
Switzerland 1951–71 –3.44* 1971–94 –4.41*
UK 1950–60 –1.25* 1960–75 –1.97* 1975–88 –2.81* 1988–99 –4.60*
Eastern countries 1953–60 –2.45* 1960–63 1.57 1963–72 –2.29* 1972–98 –2.87*
European Union 1952–64 –1.20* 1964–73 –2.67* 1973–91 –3.29* 1991–98 –3.83*
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Figure 3. Joinpoint analysis (1950–1999) for gastric cancer mortality in selected European countries. Females, all ages and 35–64 years old.
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30% in both sexes for Denmark. At age 20–44 years, Danish
gastric cancer rates declined by 16% in males and 37% in females
over the last decade.
For gastric cancer, death certification has long been sufficiently
reliable to permit meaningful inference on trends for most Euro-
pean countries, particularly those from western Europe, as well
as for major central and eastern European countries, mostly in
population aged <65 years [3]. In any case, it is unlikely that any
possible change in diagnostic practices of gastric cancer can
explain such widespread and important downward trends as those
observed across Europe [10, 11].
The use of joinpoint analysis has allowed an innovative
approach to the description of the trends in gastric cancer mortal-
ity over the last five decades. Although any modelling technique
has inherent problems of interpretation, the key message from
joinpoint regression is that, in most of Europe, the fall in gastric
cancer mortality is continuing, if anything with a steeper slope,
over the most recent calendar period. The estimate of the annual
percentage change, however, is a measure of the proportional fall
in gastric cancer death rates, and, on a public health level, has to be
translated in absolute figures.
During the 1990s, gastric cancer was the main determinant of
the fall observed in cancer mortality in the EU [5]. Even assuming,
as suggested by the present analysis, a persisting fall in gastric
cancer mortality over the next decade, the number of deaths avoided
in the first decade of the current century will probably not be
greater than 15 000. These figures will remain appreciably larger
in central and eastern European countries, and most of all in the
Russian Federation, where gastric cancer remains a public health
priority [12].
The reasons for the generalized declines in gastric cancer rates
throughout Europe are complex and not completely understood.
Almost certainly, these include a more varied and affluent diet and
better food conservation, including refrigeration, as well as the
control of Helicobacter pylori infection [4, 13–15] and reduced
tobacco smoking, at least in males [16]. Whether improved diag-
nosis and treatment has also played some role on the favorable
trends in gastric cancer throughout Europe, particularly over most
Table 4. Joinpoint analysis (1950–1999) for gastric cancer (females, all ages)
*The APC is statistically significantly different from 0 (P <0.005).
APC, annual percentage change.
Trend 1 Trend 2 Trend 3 Trend 4 Trend 5
Years APC Years APC Years APC Years APC Years APC
Austria 1955–64 –1.51* 1964–99 –4.10*
Belgium 1954–60 –1.27 1960–83 –4.26* 1983–95 –5.68*
Bulgaria 1964–70 –5.71* 1970–99 –3.10*
Former Czech Rep. 1953–66 –1.60* 1966–91 –3.98*
Denmark 1951–64 –3.71* 1964–67 –8.86 1967–98 –4.21*
Finland 1952–75 –5.15* 1975–86 –3.00* 1986–91 –5.98*
France 1950–60 –1.98* 1960–98 –4.38*
Germany 1959–65 –2.78* 1965–84 –4.11* 1984–96 –3.20* 1996–99 –5.93*
Greece 1961–79 –2.11* 1979–83 –4.92 1983–98 –2.31*
Hungary 1955–71 –2.09* 1971–85 –4.00* 1985–99 –2.23*
Ireland 1950–70 –1.82* 1970–98 –4.45*
Italy 1951–69 –1.75* 1969–77 –4.00* 1977–88 –2.48* 1988–98 –3.99*
The Netherlands 1950–62 –4.63* 1962–66 –1.74 1966–80 –4.82* 1980–99 –3.88*
Norway 1951–98 –4.13*
Poland 1959–63 4.47* 1963–68 –2.23* 1968–71 –5.89* 1971–99 –3.59*
Portugal 1955–68 1.37* 1968–99 –2.53*
Romania 1959–62 5.05* 1962–66 –7.91* 1966–77 –2.34 1977–85 –5.57* 1985–99 –1.74*
Spain 1951–63 1.05* 1963–75 –2.74* 1975–81 –6.36* 1981–98 –3.45*
Sweden 1951–53 1.56 1953–62 –5.10* 1962–98 –3.93*
Switzerland 1951–94 –4.81*
UK 1950–79 –2.77* 1979–99 –4.24*
Eastern Countries 1953–59 –3.79* 1959–65 –0.78* 1965–87 –3.79* 1987–98 –2.75*
European Union 1952–64 –2.08* 1964–74 –3.43* 1974–98 –3.67*
345
recent calendar periods, however, remains open to question [17,
18].
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